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Abstract
Objective: To assess the long-term impact of standard lobectomy on respiratory function in octogenarian patients with mild/moderate chronic
obstructive pulmonary disease (COPD).Methods:We reviewed all octogenarians (n = 38), who underwent lobectomy for stage I—II non-small-cell
lung cancer (NSCLC) from 2000 to 2006. Inclusion criteria were: Tiffenau index < 0.7, no adjuvant therapies, smoking cessation after surgery,
spirometric data available after 12  3 months from surgery in the absence of relapsing disease. Results: After excluding 14 patients (three died
perioperatively), 24 fulfilled the inclusion criteria. The median preoperative forced expiratory volume in 1 s (FEV1) was 80% (range 56.7—100%).
Themean change in FEV1 after lobectomy resulted in a loss of 11% (range32% to +7%, p = 0.004). Considering two groups on the basis of median
FEV1 (group 1: FEV1  80%, group 2: FEV1 > 80%), mean FEV1 loss after surgery was 7.9% in group 1 and 14.9% in group 2, respectively ( p = 0.17).
No statistical differences were found between the two groups in changes after surgery of forced vital capacity (FVC), arterial oxygen and carbon-
dioxide tension. Diffusion capacity of the lung for carbon monoxide (DLCO)% loss was significantly higher in group 2 compared with group 1
(22.5% vs +1.5%, p = 0.001). Six patients showed an improvement of postoperative FEV1: all had a preoperative FEV1 less than 60%, an upper or
homogeneous pattern of emphysema, and received an upper lobectomy. In group 2, the FEV1 loss was not affected by the type of lobectomy
whereas in group 1, the resection of lower lobe was associated to a major FEV1 loss (14.5% vs +5.3%, p = 0.05). Conclusions:Octogenarians with
lower preoperative FEV1% have a better late preservation of pulmonary function after lobectomy. Upper lobectomy seems to produce a lung-
volume reduction effect, leading to an improvement in the expiratory volume in patients with higher airflow obstruction.
# 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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European Journal of Cardio-thoracic Surgery 39 (2011) 555—5591. Introduction
Lung cancer is actually the primary cause of death by
malignancy in the world. To date, radical surgical resection
offers the major chance of cure and among the types of lung
resection, anatomical lobectomy represents the gold stan-
dard, even for small peripheral cancers.
The aim of the present study is to assess the long-term
respiratory functional results in octogenarians with airflow
obstruction, who had undergone lobectomy for non-small-
cell lung cancer (NSCLC), to analyze factors predicting
pulmonary function loss in these patients.§ Presented at the 17th European Conference on General Thoracic Surgery,
Krakow, Poland, May 31—June 3, 2009.
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The lung-cancer database of the Thoracic Surgery Unit at
the University of Siena was reviewed to identify all patients
agedmore than or equal to 80 years, who underwent curative
lung resection for NSCLC, from January 2000 to December
2007.
Functional assessment included medical history, physical
examination, routine blood tests, electrocardiogram, echo-
cardiography, blood gas analysis, spirometry, and estimation
of diffusion capacity of the lung for carbon monoxide (DLCO).
Cardiac stress tests and coronary angiography were per-
formed when indicated by a history of angina pectoris, or
significant ischemic signs in the basal electrocardiogram.
Lung-perfusion scintigraphy was performed in case of
predicted postoperative forced expiratory volume in 1 s
percentage (ppoFEV1%) less than 40% (computed on the basis
of pulmonary segments to be removed).
Inclusion criteria were Tiffenau index (FEV1%/forced vital
capacity percentage (FVC%)) 0.7, standard lobectomy as
surgical procedure (no combined chest-wall resection orSurgery. Published by Elsevier B.V. All rights reserved.
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after surgery, spirometric data available after 12  3 months
from surgery in the absence of local relapsing disease, or
exacerbation of chronic obstructive pulmonary disease
(COPD).
Out of 96 patients operated on from 2000 to 2006, 24
fulfilled all inclusion criteria and formed the population of
the study. No patients presented atelectasis or obstructive
pneumonia of lobe to be resected. Pulmonary function tests
(PFTs) were performed after bronchodilator inhalation to
eliminate the variable component of airflow impairment.
Airflow obstruction (COPD) was defined by a Tiffenau index
<0.7.
Roentgenographic pattern of emphysema was established
according to the criteria proposed by Goddard and colleagues
for computed tomography (CT) scan [1]; the attenuation
value of lung parenchyma (between 600 and 900
Hounsfield Unit) was used to compute the percentage of
functioning tissue resected and to correct the ppoFEV1, as
proposed by Wu and colleagues [2], because lung-perfusion
scintigraphy was performed only in patients with worst
preoperative PFT. This method had been demonstrated to be
a valid substitute of lung-perfusion scintigraphy, with a good
correlation of values found by the two methods [3].
Follow-up information was obtained either during out-
patient visits or by telephone interviews with the patient or
his/her relative, or physician. Follow-up was completed in all
patients within June 2008.
Data were analyzed using Statistical Package for Social
Science (SPSS) software 13.0 (SPSS Inc., Chicago, IL, USA).
Unpaired t-test and Mann—Whitney U-test were used for
comparison of means of continuous variables between
groups, while paired t-test was used to assess differences
within groups between preoperative and postoperative
spirometric values. Chi-square or Fisher’s exact test was
used for categorical variables. Correlation with curveTable 1. Main demographic, clinical and pathological data of population.
Group 1
Age (mean  SD) 80.6  0.4 year
Gender (%):
Male 10 (83.3)
Female 2 (16.7)
Smokers before surgery (%) 12 (100)
Co-morbidities (%) 8 (66.7)
Pts with more than one co-morbidity (%) 4 (33.3)
Respiratory parameters
FEV1 (mean % of predicted value  SD) 67.8 (8.6)
FVC (mean % of predicted value  SD) 81.7 (10.9)
RV (mean % of predicted value  SD) 140.9 (41.4)
Motley index 1.33 (0.22)
COPD index 1.32 (0.12)
DLCO (mean % of predicted value  SD) 104.5 (19.9)
PaO2 (mean  SD) 81.9 (6.6)
PaCO2 (mean  SD) 37.6 (3)
pH 7.41 (0.01)
Pathological stage (%)
I 8 (66.7)
II 3 (25)
III 1 (8.3)
Histology
Adenocarcinoma 8 (66.7)
Squamous cell c. 3 (25)
Other 1 (8.3)
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preoperative FEV1 (considered as continuous variable) and
postoperative percentage of FEV1 loss. A p value less than
0.05 was considered statistically significant.
3. Results
Demographic, clinical, and pathologic characteristics are
summarized in Table 1.
Patients were categorized into two groups (mild vs
moderate COPD) according to the global initiative for chronic
obstructive lung disease (GOLD) criteria [4]: group 1 (G1)
FEV1% <80%; group 2 (G2) FEV1% 80%).
The two groups were homogeneous regarding the number
of patients, gender, age, pathologic stage, co-morbidities,
and histology. Table 2 shows the type of concomitant diseases
of the two groups of patients. The cumulative rate of
complications was 38% in group 1 and 25% in group 2
( p = 0.04), whereas the incidence of major complications
was not different in the two groups (15% vs 12%; p = 0.72).
Considering the whole population which this series of
patients came from, combined perioperative and in-hospital
death was 6.5% in group 1 and 11.5% in group 2 ( p = 0.35).
All patients underwent posterior-lateral muscle-sparing
thoracotomy, anatomical lobectomy, and mediastinal lymph-
node dissection. At the time of repeated PFT, no patients
suffered significant thoracic pain or exacerbation of COPD
that could have worsened spirometric parameters. Post-
operative Eastern Cooperative Oncology Group (ECOG) status
(according to the criteria proposed by Eastern Cooperative
Oncology Group) was not different between the two groups.
Comparing preoperative and postoperative PFT in group 1,
we observed a statistically significant variation only for FVC%
(81.7 vs 68.4, p = 0.016) and for residual volume percentage
(RV%) (140.9 vs 105.2, p = 0.048), while FEV1% dropping fromGroup 2 p values
s 81.5  1 years 0.88
12 (100) 0.68
11 (91.6) 0.55
6 (50) 0.49
5 (41.6)
88.5 (7.9) <0.001
96.8 (5.2) <0.001
133.2 (25.5) 0.33
1.24 (0.05) 0.26
1.54 (0.13) 0.001
88.1 (11.6) 0.49
76 (1.9) 0.079
41.3 (2.8) 0.084
7.40 (0.01) 0.27
9 (75) 0.66
3 (25) 0.79
0 0.45
4 (33.3) 0.09
6 (50) 0.15
3 (16.7) 0.22
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Table 2. Co-morbidities.
Co-morbidity Patients
(Group 1)
Patients
(Group 2)
Hypertension 4 6
CAD 1 1
Kidney failure (Creatinine>2 mg/dl) 2 2
Vascular disease 0 2
Diabetes mellitus 1 0
Chronic atrial fibrillation 1 0
Heart valvular disease 0 2
Table 4. Mean variations of spirometric and arterial blood gas values before
and after surgery in Group 2.
Before surgery After surgery p values
FEV1% 88.3 (7.9) 73.7 (4.7) <0.001
FVC% 96.8 (5.2) 90.6 (17.1) 0.11
RV% 133.2 (27.1) 96 (25.3) <0.001
DLCO% 88.4 (11.6) 65.5 (12.8) 0.001
DLCO/VA% 83 (38.4) 91.3 (22.7) 0.38
PaO2 76 (7.6) 69.3 (5.1) 0.12
PaCO2 41.3 (4.9) 40.4 (4.4) 0.87
pH 7.40 (0.04) 7.38 (0.01) 0.91
Downloaded f
by Azienda O
on 31 Januar67.8 to 59.1 did not reach a significance ( p = 0.06). In group
2, FEV1% (88.3—73.7, p < 0.001), RV% (133.2—96, p < 0.001)
and DLCO% (88.4—65.5, p = 0.001) showed significant varia-
tions. Reduction of RV% was significant in both groups; see
Tables 3 and 4.
Comparing the variation of PFT parameters between the
two groups, we note that mean FEV1 loss after surgery was
7.9% in group 1 and 14.9% in group 2, although the
statistical difference was not significant ( p = 0.17); further,
differences in FVC% between the two groups were not
remarkable (13.3% in group 1 and 6.7% in group 2;
p = 0.33). DLCO% loss was much higher in group 2 than in
group 1 (22.5 vs +1.5, p = 0.001), but the difference was no
more significant considering DLCO% corrected by alveolar
ventilation (VA), (Table 5).
Six patients among 24 showed an improvement of actual
postoperative FEV1%, ranging from +1.5 to +7.3 compared
with the preoperative value. All of these patients had a
preoperative FEV1% lower than 60% and had undergone an
upper lobectomy. Type of lobectomy had no influence in
FEV1% loss in group 2 (upper lobectomy: 14.5%; lower
lobectomy: 15.6%, p = 0.81), while it reached statistical
significance in group 1 (upper lobectomy: +5.4%; lower
lobectomy: 14.5%, p = 0.05), (Table 6). Actual postopera-
tive FEV1% (apoFEV1%) and ppoFEV1% ratio was calculated
for each patient:mean apo/ppoFEV1%was higher in patients
of group 1, who received an upper lobectomy (1.32),
compared with the other three categories in which ratio was
almost equal to 1.
It must be pointed out that the same six patients, who
gained advantage from surgery, had a homogeneous or upper-
lobe pattern emphysema as confirmed by both CT scan and
lung-perfusion scintigraphy.
Considering FEV1 as a continuous variable, linear regres-
sion analysis showed a significant inverse correlation
between preoperative value of FEV1% and FEV1 percentage
loss after surgery (B: 0.63, R2: 0.46; p < 0.01), thusTable 3. Mean variations of spirometric and arterial blood gas values before
and after surgery in Group 1.
Before surgery After surgery p values
FEV1% 67.8 (8.6) 59.1 (8.7) 0.06
FVC% 81.7 (10.9) 68.4 (13.1) 0.016
RV% 140.9 (45.1) 105.2 (39.9) 0.048
DLCO% 71 (13.9) 72.5 (12.1) 0.182
DLCO/VA 104.5 (9.8) 112 (34.6) 0.76
PaO2 81.9 (9.6) 68.4 (6.6) 0.66
PaCO2 37.6 (3.7) 35.2 (2.8) 0.71
PH 7.41 (0.02) 7.43 (0.01) 0.88
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preoperative FEV1% and vice versa (Fig. 1).
Regarding blood gas tests, in group 1, the difference in
PaO2, PCO2, and pH before and after surgery was not
significant. Patients of group 2 showed a significant PaO2
decrease after surgery. No differences were found between
the two groups at the time of follow-up (Tables 3 and 4).
4. Discussion
In recent years, the percentage of patients aged more
than 80 years referred to our Institution has constantly grown
from 2.3% in the early 1990s to 8% in 2000 and 14% in 2007.
Advanced age and increasing prevalence of major co-
morbidities have made patients with NSCLC even more
difficult to be scheduled for surgery. Because of the common
risk factors underlying the two diseases (smoking, age), many
patients with resectable tumors also present COPD with
various grades of airflow obstruction. It is well known that
patients with severe emphysema and low preoperative FEV1
are at high risk of complications and a poor clinical outcome.
Octogenarians are often denied lobectomy in favor of sub-
lobar resections as a compromise operation, mainly because
of low preoperative respiratory function and co-morbidities
as also because of their advanced age. In our experience,
further, octogenarian patients with NSCLC in stage I and II,
who have reached a remarkable long-term survival and life
expectancy, are more often limited by relapsing disease
rather than age or co-morbidities [5].
On the other hand, lung-volume reduction surgery (LVRS)
has been demonstrated to improve lung function in properly
selected patients with severe emphysema. McKenna and
colleagues [6] reported in 1997 that improvement in
ppoFEV1% and dyspnea score was more evident in patients
aged under 70 years, although the differences were not
statistically significant. A growing number of studies in theTable 5. Comparison in variations of spirometric parameters between the two
Groups.
Group 1 Group 2 p values
FEV1% 7.9 (13.1) 14.6 (10) 0.17
FVC% 13.3 (16.1) 6.753(16.2) 0.33
RV% 35.2 (48.7) 36.700 (9.2) 0.94
DLCO% +1.5 (1.7) 22.5650 (17.9) 0.02
DLCO/VA 21.4 (28.3) 8.2733 (31.4) 0.47
PaO2 3.5 (5.1) 6.7 (4.3) 0.15
PaCO2 2.4 (5.7) 0.9 (1.6) 0.46
PH +0.02 (0.2) 0.02 (0.1) 0.21
C. Rapicetta et al. / European Journal of Cardio-thoracic Surgery 39 (2011) 555—559558
Table 6. Variations of FEV1.
Number of patients Mean (SD) Range p values
Group 1 Upper lobectomy 4 5.35 (2.25) 3.4—7.3 0.005
Lower lobectomy 8 14.55 (10.86) 24.6—2.2
Group 2 Upper lobectomy 8 14.05 (11.77) 32.1 to 3 0.806
Lower lobectomy 4 15.67 (6.55) 21.3—10
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function after lobectomy in some patients with moderate/
severe COPD [7], or at least a better apoFEV% than ppoFEV1%.
In such cases, the authors have hypothesized that lobectomy
could have a LVRS effect [8]. In the evaluation of patient
candidates for surgery, spirometry is still considered the gold
standard: ppoFEV1% is the most powerful predictor of
medical postoperative mortality and morbidity as demon-
strated by Kearney and colleagues [9]. The second-level
assessments as inhalation-perfusion lung scintigraphy and
cardio-respiratory exercise test may be useful in further
evaluation of ‘critical’ patients: however, while they
demonstrated valid predictors of postoperative complica-
tions, they did not clearly show a higher accuracy than simple
ppoFEV1% obtained by calculation of broncho-pulmonary
segments removed [3]. These data from literature suggested
to us that even elderly patients with less severe COPD could
obtain some benefit from resection of emphysematous
parenchyma and, therefore, in the decision-making process
that leads to schedule an octogenarian for lung surgery;
additional considerations should be made in evaluating
respiratory function: apart from preoperative FEV1%, even
ppoFEV1% could be inaccurate in some cases in predicting the
real post-surgical lung reserve loss.
It is now clear that lung-volume reduction benefits act
throughout to augment elastic recoil of small bronchi in the
remaining lung and favorable thoracic-wall remodeling with
improved respiratory motion and use of diaphragm [10].
Dyspnea is also relieved by drop of total lung capacity and use
of accessory respiratory muscles [11].
Patients of this series obviously did not accomplish the
criteria for LVRS and, on the other hand, lobectomy is not the
standard surgical option for lung-volume reduction. The[(Fig._1)TD$FIG]
Fig. 1. Correlation between preoperative FEV1% and variations of FEV1% after
surgery.
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emphysematous tissue, can explain why group 1 patients
showed, after lobectomy, a significant FVC% loss that is not
observed after LVRS. However, some physiological effects of
LVRS remain and are responsible of the remarkable drop of
RV% and the not-significant loss in FEV% after surgery in group
1: DLCO showed a gain of +1.5 at follow-up, probably due to
improvement in the ventilation—perfusion ratio. On the
contrary, in group 2 patients with better-preserved pulmon-
ary function, lobectomy strongly diminished FEV1% and also
DLCO%, because of the resection of a major portion of
functioning lung. These results confirmed reports of other
authors [12,13] that pointed out a better pulmonary function
preservation in patients with major airflow obstruction.
It must be noted that most of these studies report
functional results after 1, 3, or 6 months: at this time, the
post-thoracotomy pain could be still present in some cases,
maybe causing a restrictive pattern and, consequently, a bias
of the results [11]. In our series, all patients received a
posterolateral muscle-sparing thoracotomy, reducing a
possible factor conditioning the amount of thoracic pain.
The benefit of an upper lobectomy with regard to lower
lobectomy in our series has emerged in patients with higher
airflow impairment (group 1), even in case of homogeneous
emphysema. This contrasts with the report of Sekine and
colleagues [14], who found in their series a better
preservation of lung function post-lower lobectomy. Never-
theless, they could not prove the reason adduced to this
phenomenon, because the narrowing of lower lobar bronchus
following anatomical repositioning after upper lobectomy
has never been demonstrated. Probably, the better results
after upper lobectomy simply reflect predominantly upper-
lobe emphysema, and the same physiopathologic considera-
tions should be valid in any case of resection of less-
functioning lung lobe, but we have no data about this.
Besides, it should be kept in mind that, even after LVRS with
appropriate indication, in some cases, ppoFEV1% and FVC%
are inaccurate and, on the other hand, clinical outcome and
effort tolerance do not necessarily correlate with post-
operative PFT. In another work on the same series of patients,
we demonstrated that major complications were related to
resection of more than one lobe or combined lung and chest-
wall resections and mortality was acceptable after lobect-
omy (8.4%) [5].
ECOG status and dyspnea score did not differ significantly
between preoperative and postoperative period neither in
the original series nor in this smaller one: in particular, after
surgery, global performance status and exercise tolerance
seems to reach a similar level in both mild and moderate
COPD patients (groups 1 and 2).
In conclusion, lobectomy, if necessary to achieve a radical
resection, is a feasible option in octogenarian patients: in case
of poor respiratory reserve, additional considerations should
C. Rapicetta et al. / European Journal of Cardio-thoracic Surgery 39 (2011) 555—559 559
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ppoFEV1% is inaccurate in particular cases. These more-
compromised patients could benefit from a preoperative
physiotherapic pulmonary rehabilitation program: in this way,
it could be possible to minimize the rate of minor post-
operative complications that are probably related to 1st day
FEV1% as suggested by Varela and colleagues [15]. Lung
volumes remodeling, in fact, takes at least some months to
complete and favorableeffects are not immediatelyavailable.
The present study suffers from some limitations. It is
difficult to eliminate bias such as the preoperative optimiza-
tion of respiratory reserve through medications (steroids,
bronchodilators, and antibiotics) and the postoperative
programs of physical rehabilitation. We tried to select a
homogeneous cohort of patients with strict inclusion criteria
to establish the pure effect of lobectomy after a long time,
enough to allow the remodeling processes of lung and
thoracic wall until the final steady result. This selection has
produced a small series, often not sufficient to reach statistic
significance in some tests.
Lung-perfusion scintigraphy was not routinely performed;
hence, we had to use the CTscan estimationmethod to obtain
corrected ppoFEV1%: the few cases that were studied with
lung scintigraphy, however, demonstrated almost equal
values.
Finally, the retrospective nature of the study itself implies
that some patients were denied surgery; therefore, for
example, we have no available data of patients with lower
preoperativeFEV1andahomogeneous patternof emphysema,
who received a lower lobectomy; hence, the benefit of upper
lobectomy could only be deduced on a physiological basis.
In conclusion, also in octogenarian patients withmoderate
COPD, there is a better preservation of pulmonary function
than predicted. Upper lobectomy particularly seems to
minimize the FEV1 loss in these patients and this could
extend the indication to a curative lobectomy in a larger
number of patients with higher airway obstruction.
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